Deborah Jean Anderson PhD

Professor, Infectious Diseases

Professor, Other OB/GYN

670 Albany St | (617) 414-8482
dande@bu.edu
deborah.anderson@bmc.org

Sections

Infectious Diseases

Biography

I have expertise in mucosal immunology, and secondarily in virology. I am interested in immune defense of the genital tract against sexually-transmitted pathogens. We are currently working with epithelial cell lines and HIV-1 infection models.

Other Positions

Websites

Education

Immunology, PhD, University of Texas at Austin, 1976

Immunology, MS, University of Texas at Austin, 1974

Biology, BA, Rice University, 1971

Publications

Published on 4/13/2023

Anderson DJ, Johnston DS. A brief history and future prospects of contraception. Science. 2023 Apr 14; 380(6641):154-158. PMID: 37053322.

PubMed

Published on 3/30/2023

Mausser E, Nador E, Politch JA, Pauly MR, Marathe JG, Moench TR, Zeitlin L, Whaley KJ, Anderson DJ. LALAPG variant of the Human Contraception Antibody (HCA) reduces Fc-mediated effector functions while maintaining sperm agglutination activity. PLoS One. 2023; 18(3):e0282147. PMID: 36996137.

PubMed

Published on 3/2/2023

Thurman AR, Moench TR, Hoke M, Politch JA, Cabral H, Mausser E, Nador E, Morton J, Hamorsky K, Swope K, Bratcher B, Anderson DJ, Whaley KJ. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study. Am J Obstet Gynecol. 2023 Mar 02. PMID: 36870409.

PubMed

Published on 10/31/2022

Lee SG, Kiattiburut W, Khongkha T, Schinkel SCB, Lunn Y, Decker AP, Mohammadi A, Vera-Cruz A, Misra A, Angel JB, Anderson DJ, Baker M, Kaul R, Wang G, Tanphaichitr N. 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae. Hum Reprod. 2022 Oct 31; 37(11):2503-2517. PMID: 36053257.

PubMed

Published on 8/13/2022

Patten JJ, Keiser PT, Morselli-Gysi D, Menichetti G, Mori H, Donahue CJ, Gan X, Valle ID, Geoghegan-Barek K, Anantpadma M, Boytz R, Berrigan JL, Stubbs SH, Ayazika T, O'Leary C, Jalloh S, Wagner F, Ayehunie S, Elledge SJ, Anderson D, Loscalzo J, Zitnik M, Gummuluru S, Namchuk MN, Barabási AL, Davey RA. Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization. iScience. 2022 Sep 16; 25(9):104925. PMID: 35992305.

PubMed

Published on 9/2/2021

Anderson DJ. Passive immunization of the human vagina. Hum Vaccin Immunother. 2022 Apr 29; 18(2):1965423. PMID: 34473605.

PubMed

Published on 7/10/2021

Baldeon-Vaca G, Marathe JG, Politch JA, Mausser E, Pudney J, Doud J, Nador E, Zeitlin L, Pauly M, Moench TR, Brennan M, Whaley KJ, Anderson DJ. Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women. EBioMedicine. 2021 Jul; 69:103478. PMID: 34256345.

PubMed

Published on 2/3/2021

Politch JA, Cu-Uvin S, Moench TR, Tashima KT, Marathe JG, Guthrie KM, Cabral H, Nyhuis T, Brennan M, Zeitlin L, Spiegel HML, Mayer KH, Whaley KJ, Anderson DJ. Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial. PLoS Med. 2021 02; 18(2):e1003495. PMID: 33534791.

PubMed

Published on 8/4/2020

Anderson DJ, Politch JA, Cone RA, Zeitlin L, Lai SK, Santangelo PJ, Moench TR, Whaley KJ. Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†. Biol Reprod. 2020 08 04; 103(2):275-285. PMID: 32607584.

PubMed

Published on 8/1/2019

Anderson DJ. Population and the Environment - Time for Another Contraception Revolution. N Engl J Med. 2019 Aug 01; 381(5):397-399. PMID: 31365795.

PubMed

View full list of 299 publications.